Enspectra Health, a 2018 Rosenman Innovator, announced FDA clearance for the VIO System, which has tremendous potential for evaluating skin […]
FDA Clearance Marks Milestone in Real-Time Skin Cell Visualization

Enspectra Health, a 2018 Rosenman Innovator, announced FDA clearance for the VIO System, which has tremendous potential for evaluating skin […]
Encellin has secured $9.9M in financing to advance its groundbreaking Encapsulated Cell Replacement Therapy (EnCRT) for Type 1 Diabetes (T1D). […]
2020 Rosenman Innovator, Nanochon, received an investment for their regenerative cartilage technology. The investment will enable Nanochon to continue development […]
Savage Medical, a 2023 Rosenman Innovator, raised $3M for its minimally invasive solution that aims to eliminate surgeries and complications […]
Surgical technology company Centese announced the successful closing of its $15M Series B round led by UCSF Rosenman Institute partner […]
Venous disease and lymphedema treatment took a step forward with Koya Medical’s $30M financing. The 2020 Rosenman Innovator will continue […]
Neurovalens, a 2022 Rosenman Innovator, received FDA 510(k) clearance for their non-invasive device to treat chronic insomnia with electrical pulses. […]
The specialty care platform built for the tens of millions of women living with hormonal and gynecologic conditions, Allara Health, […]
Midi Health, a 2022 ADAPT finalist, is on a mission to revolutionize midlife care for women, and they’ve just hit […]
Targeted drug delivery technology takes a step forward with Suono Bio’s exclusive patent option agreement for the first-in-kind “RoboCap” electromechanical […]